About Nivagen Pharmaceuticals
Nivagen Pharmaceuticals is a company based in Sacramento (United States) founded in 2009 was acquired by Pharmaceutical Associates in January 2026.. Nivagen Pharmaceuticals has raised $30.97 million across 5 funding rounds from investors including Pharmaceutical Associates, BizCap and Telegraph Hill Partners. The company has 33 employees as of March 28, 2024. Nivagen Pharmaceuticals offers products and services including CDMO Services, Generic Prescription Drugs, Specialty Drugs, and Over-the-Counter Products.
- Headquarter Sacramento, United States
- Employees 33 as on 28 Mar, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nivagen Pharma (India) Private Limited
- Date of Incorporation 05 Oct, 2018
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$1.08 M (USD)99.28as on Mar 31, 2022
-
Net Profit
$123.77 K (USD)107.25as on Mar 31, 2022
-
EBITDA
$187.77 K (USD)90.02as on Mar 31, 2022
-
Total Equity Funding
$30.97 M (USD)
in 5 rounds
-
Latest Funding Round
$5 M (USD), Series B
Aug 09, 2023
-
Investors
Pharmaceutical Associates
& 2 more
-
Employee Count
33
as on Mar 28, 2024
-
Acquired by
Pharmaceutical Associates
(Jan 06, 2026)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nivagen Pharmaceuticals
Nivagen Pharmaceuticals offers a comprehensive portfolio of products and services, including CDMO Services, Generic Prescription Drugs, Specialty Drugs, and Over-the-Counter Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers drug development and manufacturing for partners.
Develops and markets affordable generic drugs for North America.
Produces sterile injectables and formulations for institutional use.
Markets non-prescription drugs for everyday consumer needs.
Unlock access to complete
Funding Insights of Nivagen Pharmaceuticals
Nivagen Pharmaceuticals has successfully raised a total of $30.97M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $5 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $5.0M
-
First Round
First Round
(14 Sep 2017)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Series B - Nivagen Pharmaceuticals | Valuation |
investors |
|
| Sep, 2022 | Amount | Debt – Conventional - Nivagen Pharmaceuticals | Valuation |
investors |
|
| May, 2020 | Amount | Series B - Nivagen Pharmaceuticals | Valuation | Telegraph Hill Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nivagen Pharmaceuticals
Nivagen Pharmaceuticals has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Pharmaceutical Associates, BizCap and Telegraph Hill Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Founded Year | Domain | Location | |
|
Small & middle market focused investment bank
|
Founded Year | Domain | Location | |
|
Generic liquid drugs are manufactured by Pharmaceutical Associates.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nivagen Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nivagen Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nivagen Pharmaceuticals Comparisons
Competitors of Nivagen Pharmaceuticals
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nivagen Pharmaceuticals
Frequently Asked Questions about Nivagen Pharmaceuticals
When was Nivagen Pharmaceuticals founded?
Nivagen Pharmaceuticals was founded in 2009 and raised its 1st funding round 8 years after it was founded.
Where is Nivagen Pharmaceuticals located?
Nivagen Pharmaceuticals is headquartered in Sacramento, United States. It is registered at Sacramento, California, United States.
Who is the current CEO of Nivagen Pharmaceuticals?
Jay Shukla is the current CEO of Nivagen Pharmaceuticals.
Is Nivagen Pharmaceuticals a funded company?
Nivagen Pharmaceuticals is a funded company, having raised a total of $30.97M across 5 funding rounds to date. The company's 1st funding round was a Series B of $15.97M, raised on Sep 14, 2017.
How many employees does Nivagen Pharmaceuticals have?
As of Mar 28, 2024, the latest employee count at Nivagen Pharmaceuticals is 33.
What is the annual revenue of Nivagen Pharmaceuticals?
Annual revenue of Nivagen Pharmaceuticals is $1.08M as on Mar 31, 2022.
What does Nivagen Pharmaceuticals do?
Nivagen Pharmaceuticals was founded in 2009 and is based in Sacramento, United States. Operations focus on the pharmaceutical sector, where generic drugs are developed and manufactured through contract services. Tablets, capsules, ointments, and solutions form the core product range. The company supports generic drug production for various clients in the healthcare industry.
What products or services does Nivagen Pharmaceuticals offer?
Nivagen Pharmaceuticals offers CDMO Services, Generic Prescription Drugs, Specialty Drugs, and Over-the-Counter Products.
Who are Nivagen Pharmaceuticals's investors?
Nivagen Pharmaceuticals has 3 investors. Key investors include Pharmaceutical Associates, BizCap, and Telegraph Hill Partners.